Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Atrial fibrillation].

M G Hennersdorf1, B E Strauer

  • 1Klinik für Kardiologie, Pneumologie und Angiologie, Medizinische Klinik und Poliklinik B, Heinrich-Heine-Universität, Moorenstrasse 5, 40225, Düsseldorf, Germany. hennersdorf@med.uni-duesseldorf.de

Der Internist
|September 5, 2006
PubMed
Summary

Atrial fibrillation (AF) management requires addressing underlying conditions and considering antiarrhythmic drugs or cardioversion for symptomatic patients. Newer treatments offer hope for improved efficacy and safety in managing this common arrhythmia.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Autonomic dysfunction in cardiopulmonary diseases].

Der Internist·2002
Same author

[Autonomic dysfunction in heart diseases and diabetes mellitus. Monitoring and diagnosis].

Der Internist·2002
Same author

Successful thrombolysis of st. Jude medical aortic prosthesis with tissue-type plasminogen activator in a pregnant woman: a case report.

Cardiology in review·2002
Same author

Left ventricular diastolic dysfunction as an early manifestation of diabetic cardiomyopathy.

Cardiology·2002
Same author

[Cardiological diagnosis in patients with obstructive sleep apnea].

Deutsche medizinische Wochenschrift (1946)·2002
Same author

[Duplex ultrasound determination of shunt volume in iatrogenic arteriovenous fistulas after heart catheterization].

Zeitschrift fur Kardiologie·2002

Area of Science:

  • Cardiology
  • Electrophysiology

Context:

  • Atrial fibrillation (AF) is the most common arrhythmia leading to hospitalization.
  • An aging population and increasing comorbidities suggest a rising AF prevalence.
  • Current therapeutic outcomes for AF are often suboptimal.

Purpose:

  • To outline current diagnostic and therapeutic strategies for atrial fibrillation.
  • To discuss the role of antiarrhythmic drugs and electrical cardioversion.
  • To review the necessity of anticoagulation and the benefits of specific medications.

Summary:

  • Diagnosis and treatment of underlying diseases are paramount in AF management.
  • Symptomatic patients, especially with persistent AF, benefit from electrical cardioversion.
  • Antiarrhythmic therapy involves drug classes Ia, Ic, and III, with necessary anticoagulation.

Related Experiment Videos

  • ACE inhibitors and AT blockers improve sinus rhythm stability post-cardioversion in hypertensive or heart failure patients.
  • Aspirin (ASS) is only indicated in specific low-risk patients; coumarin derivatives are required for those with risk factors.

    • Impact:

    • Highlights the importance of individualized treatment approaches for atrial fibrillation.
    • Emphasizes the need for effective anticoagulation to prevent thromboembolic events.
    • Suggests that advancements in anticoagulation and antiarrhythmic medications may enhance future AF treatment efficacy and safety.